AMADY | Ian Bezek | SABR | TSYHY Sabre: Time Is Running Out For This Turnaround Story (Rating Downgrade) ByMario Cazombo June 1, 2025
AGNC | ARCC | ARR | BXMT | BXSL | CHMI | CIM | Colorado Wealth Management Fund | CSWC | DX | EFC | FBRT | FSK | GAIN | GBDC | GPMT | MAIN | MFA | MITT | NLY | NYMT | OBDC | OCSL | ORC | RC | RITM | SLRC | TPVG | TSLX | TWO Fat Dividends Served Reality Check ByMario Cazombo May 29, 2025
Astrada Advisors | HTHT H World Group: Resilient Growth And Global Ambitions In A Challenging Market ByMario Cazombo June 2, 2025
Envision Research | IJR | Sensor Unlimited | SPY SPY Vs. IJR: This Chart Shows It’s Time To Buy Small Caps ByMario Cazombo June 4, 2025
ALLKA Research | ALPMF | ALPMY | BMY | BMYMP | CELG.RT | DSKYF | DSNKY | GLAXF | GSK | MRK | MRK:CA | PFE | PFE:CA | SPY Merck Proves Why It’s Still A Top Pharma Pick ByMario Cazombo May 27, 2025
BYDDF | BYDDY | Livy Investment Research | NIO | NIOIF | NVDA | NVDA:CA | XIACF | XIACY NIO Q1 2025 Earnings: Widening Losses Cast Doubt On Breakeven Ambitions ByMario Cazombo June 3, 2025
